We investigated why a clinical meticillin-resistant *Staphylococcus aureus* (MRSA) isolate, collected in Austria in late 2019, yielded false-negative results with two widely used commercial *orfX*/SCC*mec* junction assays (Cepheid GeneXpert MRSA/SA BC, BD MAX Staph SR). The aim of this study was to investigate false-negative results with these two assays. Therefore, we tested and sequenced the index isolate and other isolates assigned by microarray to the same strain (i.e. the European CC1-MRSA-IV \[[@r1]\]).

Index case
==========

A 62-year-old patient with metastasised cancer was admitted with suspected pneumonia to the Medical University Hospital of Graz, Austria. Blood cultures (BACTEC, Becton Dickinson, Heidelberg, Germany) became rapidly positive and *Staphylococcus aureus* was identified by in situ hybridisation (PNA FISH, AdvanDx, Woburn, United States (US)). In order to identify meticillin-resistant *S. aureus* (MRSA), the blood culture was investigated using the GeneXpert MRSA/SA BC PCR (Cepheid, Sunnyvale, US). Simultaneously, rapid antimicrobial susceptibility testing (RAST) was performed \[[@r2],[@r3]\]. The GeneXpert test was negative for MRSA but RAST revealed cefoxitin resistance after 6 h. Antimicrobial susceptibility testing (Vitek2, bioMérieux, Marcy-l'Étoile, France) confirmed meticillin resistance. BD MAX StaphSR (Becton Dickinson) yielded a negative MRSA result. Microarray-based characterisation (*S. aureus* Genotyping Kit 2.0, Abbott, Alere Technologies, Jena, Germany) detected *mecA* and assigned the isolate (Graz_511421--19) to clonal complex CC1-MRSA-IV. Although the antibiotic treatment was adapted, the patient died shortly after because of tumour progression.

Isolates
========

Ten CC1-MRSA-IV isolates originated from the Sfanta Parascheva Hospital, Iasi, in north-eastern Romania \[[@r4]\]. Four isolates originated from the Dresden University Hospital, Saxony, Germany. Nineteen isolates from Regensburg University Medical Centre in Bavaria, Germany and five isolates from other Bavarian hospitals were also included. All included isolates had been collected and preliminarily analysed as part of earlier collaborations. Four fully sequenced reference strains were used as controls ([Table 1](#t1){ref-type="table"}). Additional controls comprised four isolates from Dresden that belonged to local epidemic strains or to another CC1-MRSA strain (isolate Dresden-220663).

###### MRSA strains and isolates investigated in the present study and their detection using commercially available *orfX*/SCC*mec* junction site assays (n = 47)

  Isolate                       Strain affiliation (according to microarray)   SCC*mec* element                            Origin                                       BD MAX results                  GeneXpert results
  ----------------------------- ---------------------------------------------- ------------------------------------------- -------------------------------------------- ------------------------------- ----------------------
  Graz_511421-19 (index case)   CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Austria, 2019                                Negative (G)                    Negative (2 X BC; G)
  Dresden-94757                 CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Saxony, 2010                                 Negative (D, G)                 N/A
  Dresden-94758                 CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Saxony, 2014                                 Negative (D, G)                 N/A
  Dresden-94759                 CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Saxony, 2009                                 Negative (D, G)                 N/A
  Dresden-94760                 CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Saxony, 2010                                 Negative (D, G)                 N/A
  Iasi-95033                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Iasi-95034                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D)/ambiguous (G)^a^   N/A
  Iasi-95035                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D)/ambiguous (G)^a^   N/A
  Iasi-95037                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Iasi-95038                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Iasi-95039                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D)/ambiguous (G)^a^   N/A
  Iasi-95040                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Iasi-95041                    CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Iasi-174752                   CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2010                                Negative (D, G)                 N/A
  Iasi-176047                   CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Romania, 2009                                Negative (D, G)                 N/A
  Bavaria-0643                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2018                                N/A                             Positive (SSTI; R)
  Bavaria-0824                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2015                                N/A                             Positive (SSTI; R)
  Bavaria-1185                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2018                                N/A                             Positive (SSTI; R)
  Bavaria-1274                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2014                                N/A                             Positive (SSTI; R)
  Bavaria-1537                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2013                                N/A                             Positive (SSTI; R)
  Bavaria-1780                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2013                                N/A                             Positive (SSTI; R)
  Bavaria-1962                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria                                      N/A                             Positive (SSTI; R)
  Bavaria-2102                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2220                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria                                      N/A                             Positive (SSTI; R)
  Bavaria-2312                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria                                      N/A                             Positive (SSTI; R)
  Bavaria-2360                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria                                      N/A                             Positive (SSTI; R)
  Bavaria-2391                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2018                                N/A                             Positive (SSTI; R)
  Bavaria-2483                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2535                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2584                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2585                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2588                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2596                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCCmec IVa with insertion                   Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-2618                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2012                                N/A                             Positive (SSTI; R)
  Bavaria-3012                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2011                                N/A                             Positive (SSTI; R)
  Bavaria-3254                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2010                                N/A                             Positive (SSTI; R)
  Bavaria-3702                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-3741                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Bavaria-3784                  CC1-MRSA-IV (PVL-neg, *aphA3/sat*-pos)         SCC*mec* IVa with insertion                 Bavaria, 2019                                N/A                             Positive (SSTI; R)
  Dresden-220663                CC1-MRSA-IV, (PVL-neg, *aphA3/sat*-neg)        SCC*mec* IVa (as in reference strain MW2)   Saxony, 2007                                 Positive (D)                    N/A
  Dresden-124288                CC22-MRSA-IV (Barnim/UK EMRSA-15)              SCC*mec* IVh/j                              Saxony                                       Positive (D)                    N/A
  Dresden-124289                CC22-MRSA-IV (Barnim/UK EMRSA-15)              SCC*mec* IVh/j                              Saxony                                       Positive (D)                    N/A
  Dresden-124281                CC45-MRSA-IV (Berlin EMRSA)                    SCC*mec* IVa                                Saxony                                       Positive (D)                    N/A
  MU50                          CC5-MRSA-II (New York/Japan clone)             SCC*mec* II                                 Japan (sequenced reference strain)           Positive (D)                    N/A
  MW2                           CC1-MRSA-IV (PVL-pos US400)                    SCC*mec* IVa                                United States (sequenced reference strain)   Positive (D)                    N/A
  N315                          CC5-MRSA-II (New York/Japan clone)             SCC*mec* II                                 Japan (sequenced reference strain)           Positive (D)                    N/A
  US300-FPR3757                 CC8-MRSA-\[Iva-pos ACME1\] (PVL-pos ), US300   SCC \[*mec* IVa + ACME1 + Cu\]              US (GenBank CP000255.1)                      Positive (D)                    N/A

BC: GeneXpert MRSA/SA BC; CC: clonal complex; MRSA: meticillin-resistant *Staphylococcus aureus*; EMRSA: epidemic strain of MRSA; N/A: not available; PVL: Panton--Valentine leukocidin; SCCmec: staphylococcal cassette chromosome mec; SSTI: GeneXpert MRSA/SA SSTI.

D, G, and R indicate that assays were performed in Dresden, Graz and Regensburg, respectively.

^a^ Ambiguous: weak signal observed at cycle threshold Ct \> 35.

Commercial MRSA assays
======================

Test results are provided in [Table 1](#t1){ref-type="table"}. The index isolate tested negative using the BD MAX Staph SR assay (Lot 9303156). Isolates from Iasi and Dresden and controls were tested twice, in Graz and Dresden, using this assay (Graz, Lot 9303156; Dresden, Lot K55928980720210312). It failed to identify these 15 isolates although controls handled in parallel were correctly identified.

Testing of the index isolate with GeneXpert MRSA/SA BC (Lots 1000148707 and 1000179462) yielded negative results, too. Further investigations on this assay were not possible because that laboratory became involved in diagnostics for the coronavirus (Covid-19) pandemic.

All Bavarian isolates were tested using Cepheid GeneXpert MRSA/SA SSTI (Lot 1000180532) that gave correct, positive results.

Genotyping by microarray and sequencing
=======================================

All isolates were genotyped using the *S. aureus* Genotyping Kit 2.0, a microarray covering 333 different target sequences corresponding to ca 170 different genes. Target genes, assay protocols and sequences of probes and primers have been published previously \[[@r5]\]. Isolates were assigned to clonal complexes, strains and SCC*mec* types based on microarray data as described \[[@r5]\].

All isolates underwent whole-genome sequencing. DNA was extracted as for array experiments. Its quality was assessed as previously described \[[@r6]\]. The Nextera DNA Flex Library Preparation Kit (Illumina, Eindhoven, the Netherlands) was used and libraries underwent paired-end sequencing using the 500-cycle MiSeq Reagent Kit v2 (Illumina). Libraries were scaled to exhibit at least 50-fold coverage. Sequencing run quality was assured following cluster density and Q30 assessment. Raw sequence reads were trimmed using fastp 0.19.11 \[[@r7]\] and assembled using SPAdes v3.9.1 \[[@r8]\]. Contigs under 1,000 bp were removed.

The sequence of the SCC*mec* element one representative isolate, Iasi-95037, was deposited in GenBank (accession number: MT380478).

Description of the strain and its SCC*mec* element
==================================================

Microarray profiling and genome sequencing showed that the index isolate belonged to a CC1-MRSA-IV clone previously described as 'European CC1-MRSA-IV' that may have emerged in south-eastern Europe \[[@r1],[@r4],[@r9]\]. A putative, meticillin-susceptible ancestor is common in Romania where this MRSA clone frequently observed already several years ago \[[@r1],[@r4]\]. A high prevalence or outbreaks have been reported from Ireland \[[@r1]\], Italy \[[@r10]\] and Germany (North Rhine-Westphalia and Bavaria) \[[@r1],[@r11]\]. In Regensburg, retrospective microarray-based typing of 3,067 isolates revealed that the occurrence of the European CC1-MRSA-IV clone increased from \< 1% of typed MRSA between 2010 and 2013 to 9.4% in 2019. In Dresden, this strain has only sporadically been observed, accounting for seven in 1,758 isolates genotyped since 2000 (\[[@r1],[@r12]\] and data not shown). Microarray genotyping data indicated that this clone was also recovered from horses and wild birds in Austria \[[@r13],[@r14]\] and from livestock in Italy \[[@r15]\].

Isolates of this clone typically exhibit sequence type (ST)1 (1--1-1--1-1--1-1) or ST4110 (1--1-1--1-1--1-558) and *spa* types t127 (07--23--21--16--34--33--13), t386 (07--23--13) or t13790 (07--23--21--16--34--33--34--34--33--34). Isolates usually carry *ermC* (erythromycin/clindamycin resistance), *tetK* (tetracycline resistance), *aphA*3 (kana-/neomycin resistance), *aadE* (streptomycin resistance) and *sat* (streptothricin resistance). Some isolates harbour *aacA-aphD* (gentamicin resistance). Isolates from Ireland frequently exhibit resistance to mupirocin, chlorhexidine and quaternary ammonium compounds because of plasmid-borne *iles2/mupR* and *qacA* \[[@r1]\]. Fusidic acid resistance has not yet been detected in this clone, in contrast to other CC1-MRSA of from the Middle East or the southern hemisphere.

The clone is PVL-negative and lacks the *splE* protease gene. It only rarely carries enterotoxin genes *sek/seq* in addition to *seh* that is ubiquitously present in CC1. Its relationship to other CC1-MRSA clones has been discussed previously in detail \[[@r1]\].

This CC1-MRSA clone has an SCC*mec* IVa element which is essentially identical in all isolates and in a previous Irish sequence (GenBank RBVO00000000.1) \[[@r1]\]. In contrast to MW2 (BA000033.2), it harbours an insertion of ca 5,350 nt, adjacent to *orfX* ([Table 2](#t2){ref-type="table"}, [Figure](#f1){ref-type="fig"}). The insertion affects the *orfX/*SCC*mec* junction that is targeted by molecular tests for the detection of MRSA. It starts with a SCC terminal sequence alternate to *dcs* ('SCCterm 15') and encodes six hypothetical proteins (E7MHX1, *ydiL*2, C5QAP8, A8YYX4, *npd* and H4AYD7; RBVO000005.1: 280,690--286,024). This insertion replaces *dcs*/Q9XB68*-dcs* and removes most (212 of 240 nt) of a gene encoding hypothetical protein Q7A213.

###### Genes in the variant SCC*mec* IVa element of the European CC1-MRSA-IV strain

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene ID          Definition of gene product and comments (see also annotation of MH188467.1)                                    Orientation   Locus tag in MW2 (BA000033.2)   Nucleotide positions in GenBank RBVO               Nucleotide positions in GenBank MT380478 (Iasi-95037)
  ---------------- -------------------------------------------------------------------------------------------------------------- ------------- ------------------------------- -------------------------------------------------- -------------------------------------------------------
  *orfX*           23S rRNA methyltransferase                                                                                     Forward       MW0024                          RBVO01000005.1;\                                   N/A
                                                                                                                                                                                nt 280,209--280,689                                

  sRNA6            Antisense RNA associated with orfX                                                                             Reverse       N/A                             RBVO01000005.1;\                                   N/A
                                                                                                                                                                                nt 280,389--280,673                                

  DR_SCC           Direct repeat of SCC, to 19 nt of the 3\' end of the coding sequence of orfX                                   N/A           N/A                             RBVO01000005.1;\                                   nt 1--19
                                                                                                                                                                                nt 280,670--280,689                                

  sccterm15        SCC-terminal sequence adjacent to orfX, and alternate to dcs, see Discussion                                   N/A           Not present                     RBVO01000005.1;\                                   nt 20--242
                                                                                                                                                                                nt 280,689--280,912                                

  E7MHX1           Transcription regulator                                                                                        Forward       Not present                     RBVO01000005.1;\                                   nt 243--569
                                                                                                                                                                                nt 280,912--281,239                                

  *ydiL2*          Hypothetical protein/putative membrane peptidase, associated with SCC elements                                 Forward       Not present                     RBVO01000005.1;\                                   nt 606--1,439
                                                                                                                                                                                nt 281,275--282,109                                

  C5QAP8-M299      Hypothetical protein                                                                                           Forward       Not present                     RBVO01000005.1;\                                   nt 2,125--2,898
                                                                                                                                                                                nt 282,794--283,568                                

  A8YYX4           Hypothetical protein                                                                                           Reverse       Not present                     RBVO01000005.1;\                                   nt 3,136--3,474
                                                                                                                                                                                nt 283,805--284,144                                

  *npd-*SCC        Enoyl-\[acyl-carrier-protein\] reductase-like protein                                                          Reverse       Not present                     RBVO01000005.1;\                                   nt 3,660--4,730
                                                                                                                                                                                nt 284,329--285,400                                

  H4AYD7-trunc     Transcriptional regulator, LysR family                                                                         Truncated     Not present                     RBVO01000005.1;\                                   nt 4,743--5,354
                                                                                                                                                                                nt 285,412--286,024                                

  Q7A213-trunc     Putative protein; it comprises the inverted repeat of IS431. In MW2 it is not truncated and comprises 240 nt   Truncated     MW0026                          RBVO01000005.1;\                                   nt 5,355--5,382
                                                                                                                                                                                nt 286,024--286,052                                

  IR_IS431         Inverted repeat of IS431                                                                                       Truncated     N/A                             RBVO01000005.1;\                                   nt 5,355--5,370
                                                                                                                                                                                nt 286,024--286,040                                

  tnpIS431         Transposase for IS431                                                                                          Reverse       MW0027                          RBVO01000005.1;\                                   nt 5,414--6,088
                                                                                                                                                                                nt 286,083--end of contig (nt 286,184) (partial)   

  Teg143           Trans-encoded RNA associated with tnpIS431                                                                     Forward       N/A                             RBVO01000003.1;\                                   nt 6,119--6,152
                                                                                                                                                                                nt 203--237                                        

  IR_IS431         Inverted repeat of IS431                                                                                       Truncated     N/A                             RBVO01000003.1;\                                   nt 6,129--6,144
                                                                                                                                                                                nt 213--229                                        

  *mvaS-*SCC       Truncated HMG-CoA synthase                                                                                     Forward       MW0028                          RBVO01000003.1;\                                   nt 6,161--6,513
                                                                                                                                                                                nt 245--598                                        

  Q5HJW6           Hypothetical protein                                                                                           Forward       N/A                             RBVO01000003.1;\                                   nt 6,611--6,841
                                                                                                                                                                                nt 695--1,046                                      

  *dru*            SCC direct repeat units                                                                                        Truncated     N/A                             RBVO01000003.1;\                                   nt 6,751--7,148
                                                                                                                                                                                nt 835--1,273                                      

  *ugpQ*           Glycerophosphoryl diester phosphodiesterase-like protein                                                       Forward       MW0029                          RBVO01000003.1;\                                   nt 7,350--8,093
                                                                                                                                                                                nt 1,474--2,218                                    

  *ydeM*           Acyl dehydratase MaoC                                                                                          Forward       MW0030                          RBVO01000003.1;\                                   nt 8,190--8,618
                                                                                                                                                                                nt 2,314--2,743                                    

  *mecA*           Encodes penicillin binding protein 2 prime, defining MRSA                                                      Reverse       MW0031                          RBVO01000003.1;\                                   nt 8,664--10,670
                                                                                                                                                                                nt 2,812--4,795                                    

  *mecR1-*trunc    Meticillin resistance operon repressor 1, signal transducer protein, truncated in SCCmec IV                    Truncated     MW0032                          RBVO01000003.1;\                                   nt 10,770--10,816
                                                                                                                                                                                nt 4,894--5,862                                    

  *hsdR2-*IS1272   Type I site-specific deoxyribonuclease restriction subunit                                                     Truncated     MW0033                          RBVO01000003.1;\                                   nt 11,745--11,978
                                                                                                                                                                                nt 5,869--6,103                                    

  tnpIS1272        Transposase                                                                                                    Reverse       MW0034                          RBVO01000003.1;\                                   nt 11,979--13,502
                                                                                                                                                                                nt 6,103--7,627                                    

  Q9KX75           Hypothetical protein                                                                                           Reverse       MW0035                          RBVO01000003.1;\                                   nt 13,638--14,144
                                                                                                                                                                                nt 7,762--8,269                                    

  Q7A207           Hypothetical protein                                                                                           Reverse       MW0036                          RBVO01000003.1;\                                   nt 14,159--14,470
                                                                                                                                                                                nt 8,283--8,595                                    

  Q7A206-trunc     Hypothetical protein, truncated                                                                                Truncated     N/A                             RBVO01000003.1;\                                   nt 14,472--14,558
                                                                                                                                                                                nt 8,596--8,683                                    

  Q7A206           Hypothetical protein                                                                                           Reverse       MW0037                          RBVO01000003.1;\                                   nt 14,557--14,907
                                                                                                                                                                                nt 8,681--9,032                                    

  UTR\_*ccrB-2*    Highly conserved 3\'-untranslated region of *ccrB*                                                             N/A           N/A                             RBVO01000003.1;\                                   nt 14,908--15,428
                                                                                                                                                                                nt 9,032--9,553                                    

  *ccrB-2*         Cassette chromosome recombinase B2                                                                             Reverse       MW0038                          RBVO01000003.1;\                                   nt 15,429--17,057
                                                                                                                                                                                nt 9,553--11,182                                   

  *ccrA-2*         Cassette chromosome recombinase A2                                                                             Reverse       MW0039                          RBVO01000003.1;\                                   nt 17,079--18,428
                                                                                                                                                                                nt 11,203--12,553                                  

  *cch-2*          Hypothetical protein/cassette chromosome helicase                                                              Reverse       MW0040                          RBVO01000003.1;\                                   nt 18,662--20,449
                                                                                                                                                                                nt 12,786--14,574                                  

  DUF1413          Hypothetical protein, associated with cch                                                                      Reverse       MW0041                          RBVO01000003.1;\                                   nt 20,449--20,739
                                                                                                                                                                                nt 14,573--14,864                                  

  Q2FKL7           Putative membrane protein                                                                                      Forward       MW0042                          RBVO01000003.1;\                                   nt 20,878--21,927
                                                                                                                                                                                nt 15,002--16,052                                  

  Q8VUV8           Putative transcriptional regulator                                                                             Forward       MW0043                          RBVO01000003.1;\                                   nt 22,380--23,870
                                                                                                                                                                                nt 16,504--17,995                                  

  *cstB-*SCC2      Includes a putative beta-lactamase; marker for SCCm*ec* IVa                                                    Truncated     MW0045                          RBVO01000003.1;\                                   nt 24,243--25,560
                                                                                                                                                                                nt 18,367--19,685                                  

  Q2FKL3           HNH endonuclease family protein                                                                                Forward       MW0046                          RBVO01000003.1;\                                   nt 25,751--26,122
                                                                                                                                                                                nt 19,875--20,247                                  

  Q8VUW0           Putative membrane protein                                                                                      Forward       MW0047                          RBVO01000003.1;\                                   nt 26,251--26,871
                                                                                                                                                                                nt 20,375--20,996                                  

  DR_SCC           Direct repeat of SCC                                                                                           Truncated     N/A                             RBVO01000003.1;\                                   nt 27,176--27,194
                                                                                                                                                                                nt 21,300--21,319                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MRSA: meticillin-resistant *Staphylococcus aureus*; N/A: not available; nt: nucleotide position; SCC: staphylococcal cassette chromosome.
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SCCterm 15 is present in at least three other MRSA strains. In CC152-MRSA-XIII, it is close to *orfX* (MG674089, CP024998), possibly affecting MRSA PCRs. In two other strains, it is situated within complex SCC*mec* elements \[[@r16]\]. In a Danish CC8-MRSA strain (HM030720.1), the same insert as in the European CC1-MRSA is localised between an ACME-II and an SCC*mec* IVa element \[[@r17],[@r18]\]. A Saudi Arabian CC22-MRSA strain (HF569105.1) harbours SCCterm 15, E7MHX1, *ydiL*2, IR_IS431 and tnpIS431, localised between a copper resistance element and a composite ACME-II/ SCC*mec* IVh/j element \[[@r19]\].

An identical 5,350 nt cluster is present in *Staphylococcus epidermidis* P11PPP12 (MH188467.1). Beyond that, the entire SCC*mec* IV element in P11PPP12 is identical to the one in the CC1-MRSA strain. Significantly, the site of recombination cutting short Q7A213 is conserved in both strains (position 5,818/5,819 in the [Supplement](/content/10.2807/1560-7917.ES.2020.25.25.2000929#supplementary_data)). Thus, it is likely that the *entire* SCC*mec* IVa cassette including the insert was transferred between ancestors of the two strains, i.e. across the species. However, P11PPP12 also harbours an ACME-II/heavy metal resistance element downstream of SCC*mec*, which is absent from the European CC1-MRSA-IV. Therefore, it must have been lost during or after transfer of the SCC*mec* element, or it was acquired later by *S. epidermidis*.

Discussion
==========

The study demonstrates that a CC1-MRSA-IV epidemic strain in Europe can yield false-negative results with common MRSA assays (GenXpert MRSA/SA BC, BD MAX Staph SR). Interestingly, GeneXpert MRSA/SA SSTI yielded correct results, indicating that the different tests utilise different primers. The absence of *dcs* and coverage of SCCterm 15 appear to be the reason for the discrepancy.

False-negative results of PCRs targeting the *orfX*/SCC*mec* junction site are concerning. Molecular assays are used to predict MRSA in positive blood cultures and to change therapy accordingly. The use of molecular assays is beneficial for a vast majority of patients because a result is available quickly. However, these assays can only detect target sequences that were available and considered at the time the primers were designed, and false-negative results have the potential to harm the patient by delaying effective therapy. Conventional antibiotic susceptibility tests are slower but are not constrained by the choice of primers or by the presence of unknown genotypes.

Molecular assays are also used to guide infection control. False-negative tests may result in lapses facilitating further MRSA transmission. Another, less obvious consequence might be a shift in the clonal structure of MRSA populations. When molecular assays exert a selective pressure favouring a false-negative strain, PCR-positive strains might get 'penalised' with subsequent interventions, hindering proliferation and transmission. This could lead to an increasing prevalence of the false-negative strain and to more failures in therapy and infection control.

It is crucial to monitor the emergence of new SCC*mec* junction sites in *S. aureus* and in coagulase-negative staphylococci, as mobile SCC*mec* elements can readily be transmitted between different strains and species, as was the case in the strain described here. Such unknown genotypes represent a problem for established molecular assays. As illustrated here, updating existing tests and platforms to evolving genotypes of the target organisms is important for individual and public health.

The containment of the CC1 strain must rely on conventional susceptibility tests, culture-based screening using selective growth media or updated molecular tests. We propose screening of medical or nursing staff recruited from epidemic regions, not only in hospitals but also in other care facilities, as well as patients with travel histories to these regions.
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